These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33660201)

  • 1. Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives.
    Wu Z; Li T
    Pharm Res; 2021 Mar; 38(3):473-478. PubMed ID: 33660201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
    Milane L; Amiji M
    Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine and the COVID-19 vaccines.
    Nat Nanotechnol; 2020 Dec; 15(12):963. PubMed ID: 33247210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 7. The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS.
    Sato Y; Nakamura T; Yamada Y; Harashima H
    J Control Release; 2021 Feb; 330():305-316. PubMed ID: 33358975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Review of mRNA Vaccines.
    Gote V; Bolla PK; Kommineni N; Butreddy A; Nukala PK; Palakurthi SS; Khan W
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
    Copur M
    Oncology (Williston Park); 2021 Apr; 35(4):190-198. PubMed ID: 33893760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling mRNA delivery bottlenecks of ineffective delivery vectors by co-transfection with effective carriers.
    Oude Egberink R; van Schie DM; Joosten B; de Muynck LTA; Jacobs W; van Oostrum J; Brock R
    Eur J Pharm Biopharm; 2024 Sep; 202():114414. PubMed ID: 39009193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled mRNA vaccines.
    Kim J; Eygeris Y; Gupta M; Sahay G
    Adv Drug Deliv Rev; 2021 Mar; 170():83-112. PubMed ID: 33400957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi- and fully synthetic carbohydrate vaccines against pathogenic bacteria: recent developments.
    Zasłona ME; Downey AM; Seeberger PH; Moscovitz O
    Biochem Soc Trans; 2021 Nov; 49(5):2411-2429. PubMed ID: 34495299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of nanoparticles-based vaccines for COVID-19.
    Guerrini G; Magrì D; Gioria S; Medaglini D; Calzolai L
    Nat Nanotechnol; 2022 Jun; 17(6):570-576. PubMed ID: 35710950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes.
    Fornaguera C; Díaz-Caballero M; García-Fernandez C; Olmo L; Stampa-López Pinto M; Navalón-López M; Guerra-Rebollo M; Borrós S
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34459811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for childhood vaccination against COVID-19?
    Eberhardt CS; Siegrist CA
    Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new generation of vaccines based on alphavirus self-amplifying RNA.
    Ballesteros-Briones MC; Silva-Pilipich N; Herrador-Cañete G; Vanrell L; Smerdou C
    Curr Opin Virol; 2020 Oct; 44():145-153. PubMed ID: 32898764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing mRNA for Therapy.
    Karikó K
    Keio J Med; 2022; 71(1):31. PubMed ID: 35342149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
    Pascolo S
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Developments and Challenges of mRNA Vaccines.
    Chen J; Chen J; Xu Q
    Annu Rev Biomed Eng; 2022 Jun; 24():85-109. PubMed ID: 35231177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.